Research Toward a Cure Trials
Ending HIV requires sustained research. TAG’s March 2026 cure trials update tracks clinical studies worldwide, helping advocates, researchers, and communities follow progress toward a cure.
Adam Ortega
Communications Director Adam Ortega is TAG’s director of communications and joined the organization in March 2026. He spearheads the entire marketing lifecycle at TAG including graphic design, copyediting, email marketing, photography, and more. Previous to TAG, Adam worked as director…
TAG Condemns Latest U.S. “Forever” War in the Middle East, Calls for Reprogramming Billions from Military Aggression to Health and Research
TAG condemns the United States’ war in Iran and neighboring countries. At a time when U.S. investment in public health is being slashed, the Trump administration has chosen to spend billions of dollars per day on weapons used in a war of choice for which no credible rationale has been proposed. Our government should invest in our communities by spending funds that were already appropriated and illegally impounded by the White House Office of Management and Budget to keep people healthy, rather than starting new wars that put the entire world’s health at risk.
Internship Opportunity: Research Intern, TB Project
We are seeking a Research Intern to support our work advancing innovative financing strategies to accelerate tuberculosis (TB) research, development, and equitable access to lifesaving tools. In collaboration with the Senior TB Project Associate, the Research Intern will develop a research proposal and conduct research related to the relationship between the international financial architecture and investment and outcomes in TB.
TAG Condemns Illegal, Partisan CDC Cuts Proposed by White House
TAG condemns the White House’s proposed retroactive $600 million cuts to CDC programs in four states. Because Congress already appropriated these funds, the cuts are illegal and unconstitutional, threatening HIV and public health programs nationwide. Congress must reject these partisan attacks and protect public health funding.
Job Posting: Grant Officer
We're seeking a dynamic, highly motivated, and organized Grant Officer to lead TAG's grant work and support fundraising efforts. Candidates should be grant professionals with a background in domestic and global public health research, practice, and advocacy, focused on expanding and maintaining TAG’s current grant portfolio. This is a full-time, salaried role.
Act Now: End AIDS and TAG Warn Against Erasure of Black HIV Awareness, Call for Action on National Black HIV/AIDS Awareness Day
This National Black HIV/AIDS Awareness Day, Act Now: End AIDS and TAG uplift the truth: Black people are disproportionately impacted by HIV, and equity-driven solutions are essential. Ending the HIV epidemic requires confronting racism, expanding access to prevention and care, and ensuring that Black communities are centered, visible, and supported in public health efforts.
This Year, Our Board Saw Firsthand What We Are Up Against
This year revealed how far this administration is willing to go in undermining public health. The White House refused to recognize World AIDS Day. Global and domestic HIV, TB, and HCV programs were directly threatened, and many were terminated. Senior CDC leaders resigned rather than carry out political firings or oversee the degradation of national vaccine guidance. And in August, a vigilante encouraged by political rhetoric fired nearly 500 rounds into the CDC campus in Atlanta and killed a police officer. The President has still not publicly acknowledged the attack.
TAGLine 2025: A Year of Action
TAGLine 2025 documents a year of action as Treatment Action Group defended science, confronted attacks on public health, and fought to protect communities impacted by HIV, TB, and HCV.
New Report Urges Action to Ensure Sustainable, Affordable Supply of Key Vaccine Adjuvants for Global Health Use
Behind many lifesaving vaccines is a fragile supply chain that few people ever see. This new TAG report examines how weaknesses in the production and supply of key vaccine adjuvants (an ingredient that enhances the immune response) can create bottlenecks that threaten global access to vaccines, underscoring the importance of greater market transparency, security, and competitiveness among governments, funders, and pharmaceutical companies.